Illness	Number of cases
Malignant neoplasm of prostate (C61)	505
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	419
Hyperplasia of prostate (N40)	344
Gender identity disorders - Transsexualism (F64.0)	221
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	146
Calculus of kidney and ureter - Calculus of kidney (N20.0)	114
Cystitis (N30.2)	82
Unspecified haematuria (R31)	78
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2)	77
Female genital prolapse (N81.1)	67

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	3.453
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41)	552
Surgical creation of a connection between the urinary bladder and skin of the abdomen for artificial urinary drainage (5-572.1)	498
X-rays of the urinary bladder with contrast medium (3-13f)	408
Exchange or removal of a urinary catheter through the abdominal wall (8-133.1)	364
Injection or administration of medicines into the urinary bladder (8-132.1)	358
Use of an imaging procedure during an operation (3-992)	336
Surgical removal or destruction of prostatic tissue through the urethra (5-601.1)	336
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	333
Operation using a surgical robot (5-987.0)	331

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ30

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
41	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
34	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
34	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Participation in multi-centre phase III/IV studies	Teilnahme erfolgt im Rahmen unseres Studienzentrums
Participation in multi-centre Phase I/II studies	Teilnahme erfolgt im Rahmen unseres Studienzentrums
Lectureships / teaching posts at colleges and universities	Prof. Dr. med. Martin Kriegmair: Professor an der Ludwig-Maximilians-Universität München, Prof. Dr. med. Maximilian Kriegmair: Professor an der Universität Heidelberg - med. Fakultät Mannheim, CA Dr. med. Ralph Oberneder: Lehrauftrag an der Ludwig-Maximilians-Universität München
Student training (clinical traineeship / internship year)	volle Weiterbildungsermächtigung Urologie, Weiterbildungsermächtigung 18 Monate Anästhesie, Zusatz-Weiterbildung Medikamentöse Tumortherapie, Famulaturen und Pflegedienstpraktika im Rahmen des Medizinstudiums
Doctoral supervision
Editors of scientific journals/textbooks